# Multiple Daily Condensed Tannin Supplementation and Iron Bioavailability: The Tannin Dose Response Trial

> **NCT03030716** · NA · COMPLETED · sponsor: **Kansas State University** · enrollment: 11 (actual)

## Conditions studied

- Iron Deficiency Anemia
- Iron-deficiency

## Interventions

- **DIETARY_SUPPLEMENT:** 95% condensed proanthocyanidins from grape seed extract

## Key facts

- **NCT ID:** NCT03030716
- **Lead sponsor:** Kansas State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-25
- **Primary completion:** 2016-12-10
- **Final completion:** 2016-12-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03030716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03030716, "Multiple Daily Condensed Tannin Supplementation and Iron Bioavailability: The Tannin Dose Response Trial". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03030716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*